Working… Menu

3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02057445
Recruitment Status : Completed
First Posted : February 7, 2014
Last Update Posted : December 22, 2017
Children's National Research Institute
Baylor College of Medicine
M.D. Anderson Cancer Center
University of Michigan
University of Utah
City of Hope Medical Center
Ohio University
Johns Hopkins University
Information provided by (Responsible Party):
Mitchell Cairo, New York Medical College

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2017